Cleared Special

K160956 - LD-Oxi system

K160956 is an FDA 510(k) clearance for LD-Oxi system, manufactured by Ld Technology, LLC. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Special 510(k) pathway after a 92-day FDA review.

K160956 · Ld Technology, LLC · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2016
Decision
92d
Days
Class 2
Risk

K160956 is an FDA 510(k) clearance for the LD-Oxi system. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Ld Technology, LLC (Miami, US). The FDA issued a Cleared decision on July 6, 2016 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K160956

510(k) Number K160956 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2016
Decision Date July 06, 2016
Days to Decision 92 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d faster than avg
Panel avg: 125d · This submission: 92d
Pathway characteristics
Modification to existing cleared device.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 308
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K160956.
IQvitals Zone
K161909 · Midmark Corporation · Nov 2016
Vital Sync Informatics Manager & Virtual Patient Monitoring Platform
K160718 · Covidien · Nov 2016
AMC Health VitalCaregiving System
K151839 · Amc Health · Sep 2016
MRI Patient Monitor TeslaDUO
K153739 · Mipm Mammendorfer Institut Fur Physik Und Medizin · Jun 2016
Masimo Root Monitoring System and Accessories
K153225 · Masimo Corporation · Jun 2016
Axeo 3 Patient Monitor
K153079 · Axeo Medical Technologies, LLC · Mar 2016
K160956 · LD-Oxi system
Download PDF FDA Summary Ld Technology, LLC